• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尼日利亚阿布贾健康成年人中化脓性汗腺炎的患病率。

Prevalence of Hidradenitis Suppurativa among Healthy Adults in Abuja, Nigeria.

作者信息

Ibekwe Perpetua U, Bouazzi Dorra, Medianfar Cecilia E, Christensen Robin, Jemec Gregor B E

机构信息

Dermatology Unit, Department of Internal Medicine, University of Abuja Teaching Hospital, Abuja, Nigeria.

Department of Medicine, Faculty of Clinical Sciences, College of Health Sciences, University of Abuja, Abuja, Nigeria.

出版信息

Dermatology. 2025 Jul 7:1-5. doi: 10.1159/000539443.

DOI:10.1159/000539443
PMID:40623372
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12233965/
Abstract

INTRODUCTION

Hidradenitis suppurativa (HS) is an inflammatory disorder that affects the apocrine gland-bearing regions. There is currently no population-based study of HS in Nigeria. The purpose of this study was to investigate the prevalence of HS in Abuja, Nigeria's federal capital territory.

METHODS

This is a cross-sectional study of healthy adults accompanying patients to the outpatient clinics of the tertiary hospital in Abuja, utilizing the Global Hidradenitis Suppurativa Atlas (GHiSA) questionnaire as part of the GHiSA program.

RESULTS

The prevalence of HS in 898 participants was 3.3% (95% confidence interval (CI): 2.3%-4.7%). Participants with HS had a significantly higher body mass index than those without (p value of 0.038). One out of the 30 HS participants had a Hurley score of 2, while the rest had a Hurley score of 1. The majority of participants (49%) exhibited HS symptoms involving the axilla. The GHiSA questionnaire has a sensitivity rate of 93.8% (95% CI: 79.2%-97.3%) and a specificity rate of 93.8% (95% CI: 88.2%-97.3%).

CONCLUSION

The prevalence of HS in our study (3.3%) was higher than that seen in hospital records (0.47%). This demonstrates that most HS patients present to the dermatology outpatient clinics when the disease is severe.

摘要

引言

化脓性汗腺炎(HS)是一种影响顶泌汗腺分布区域的炎症性疾病。目前在尼日利亚尚无基于人群的HS研究。本研究的目的是调查尼日利亚联邦首都地区阿布贾HS的患病率。

方法

这是一项对陪同患者前往阿布贾三级医院门诊的健康成年人进行的横断面研究,采用全球化脓性汗腺炎地图集(GHiSA)问卷作为GHiSA项目的一部分。

结果

898名参与者中HS的患病率为3.3%(95%置信区间(CI):2.3%-4.7%)。患有HS的参与者的体重指数显著高于未患HS的参与者(p值为0.038)。30名HS参与者中有1人的Hurley评分为2分,其余人的Hurley评分为1分。大多数参与者(49%)表现出涉及腋窝的HS症状。GHiSA问卷的灵敏度为93.8%(95%CI:79.2%-97.3%),特异度为93.8%(95%CI:88.2%-97.3%)。

结论

我们研究中HS的患病率(3.3%)高于医院记录中的患病率(0.47%)。这表明大多数HS患者在疾病严重时才到皮肤科门诊就诊。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8cc5/12233965/0a5e81aa1f95/drm-2025-0000-0000-539443_F01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8cc5/12233965/0a5e81aa1f95/drm-2025-0000-0000-539443_F01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8cc5/12233965/0a5e81aa1f95/drm-2025-0000-0000-539443_F01.jpg

相似文献

1
Prevalence of Hidradenitis Suppurativa among Healthy Adults in Abuja, Nigeria.尼日利亚阿布贾健康成年人中化脓性汗腺炎的患病率。
Dermatology. 2025 Jul 7:1-5. doi: 10.1159/000539443.
2
Prevalence of Hidradenitis Suppurativa in the Netherlands: A Cross-Sectional Study as Part of the Global Hidradenitis Suppurativa Atlas (GHiSA).荷兰化脓性汗腺炎的患病率:一项作为全球化脓性汗腺炎地图集(GHiSA)一部分的横断面研究。
Dermatology. 2025 Jul 7:1-6. doi: 10.1159/000542816.
3
Prevalence of Hidradenitis Suppurativa in Serbia: Validation of a Screening Questionnaire.塞尔维亚化脓性汗腺炎的患病率:一份筛查问卷的验证
Dermatology. 2025 Jul 7:1-6. doi: 10.1159/000539877.
4
Hidradenitis Suppurativa Prevalence in Santiago, Chile.智利圣地亚哥化脓性汗腺炎的患病率
Dermatology. 2025 Jul 7:1-5. doi: 10.1159/000538423.
5
Validation of the real-world application of the Hidradenitis Suppurativa Quality of Life (HiSQOL) score to adults with hidradenitis suppurativa.化脓性汗腺炎生活质量(HiSQOL)评分在成年化脓性汗腺炎患者真实世界应用中的验证。
Br J Dermatol. 2025 Jan 24;192(2):261-268. doi: 10.1093/bjd/ljae367.
6
Prevalence of Hidradenitis Suppurativa in Poland.波兰化脓性汗腺炎的患病率。
Dermatology. 2025 Jul 7:1-9. doi: 10.1159/000541951.
7
Hidradenitis Suppurativa Prevalence in Indonesia: A Cross-Sectional Multicenter Study and Validation of a Screening Questionnaire.印度尼西亚化脓性汗腺炎患病率:一项横断面多中心研究及筛查问卷验证
Dermatology. 2025 Jul 7:1-6. doi: 10.1159/000539705.
8
Prevalence of Hidradenitis Suppurativa in Brussels, Belgium: Validation of a Screening Questionnaire.比利时布鲁塞尔化脓性汗腺炎的患病率:一份筛查问卷的验证
Dermatology. 2025 Jul 7:1-5. doi: 10.1159/000539477.
9
Prevalence of Hidradenitis Suppurativa in Darmstadt, Germany: A Contribution to the Global Hidradenitis Suppurativa Atlas.德国达姆施塔特化脓性汗腺炎的患病率:对全球化脓性汗腺炎地图集的贡献。
Dermatology. 2025 Jul 7:1-6. doi: 10.1159/000539285.
10
Prevalence of Hidradenitis Suppurativa in Balangoda, Sri Lanka.斯里兰卡巴朗戈达地区化脓性汗腺炎的患病率。
Dermatology. 2025 Jul 7:1-5. doi: 10.1159/000539336.

引用本文的文献

1
Prevalence of Hidradenitis Suppurativa: A Meta-Analysis of Global Hidradenitis Suppurativa Atlas Studies.化脓性汗腺炎的患病率:全球化脓性汗腺炎地图集研究的荟萃分析。
JAMA Dermatol. 2025 Aug 27. doi: 10.1001/jamadermatol.2025.2373.

本文引用的文献

1
The Global Hidradenitis Suppurativa Atlas Methodology: Combining Global Proportions in a Pooled Analysis.《全球化脓性汗腺炎图谱方法学:汇总分析全球比例》。
Dermatology. 2024;240(3):369-375. doi: 10.1159/000536389. Epub 2024 Feb 14.
2
Long-term risk of death in patients with hidradenitis suppurativa.化脓性汗腺炎患者的长期死亡风险。
Int J Dermatol. 2023 May;62(5):631-636. doi: 10.1111/ijd.16409. Epub 2022 Sep 13.
3
The prevalence of hidradenitis suppurativa outside the hospital setting: the impact of the undiagnosed.医院环境外的化脓性汗腺炎流行情况:未确诊的影响。
Br J Dermatol. 2022 May;186(5):767-768. doi: 10.1111/bjd.21293. Epub 2022 Apr 15.
4
Hidradenitis suppurativa prevalence in Berekum, Ghana: A cross-sectional study and initial validation of a questionnaire in an African setting.加纳贝雷库姆化脓性汗腺炎患病率:一项横断面研究及在非洲环境中对一份问卷的初步验证
JAAD Int. 2020 Apr 25;1(1):1-2. doi: 10.1016/j.jdin.2020.02.001. eCollection 2020 Jul.
5
Trends in body mass index before and after diagnosis of hidradenitis suppurativa.诊断化脓性汗腺炎前后的体重指数趋势。
Br J Dermatol. 2021 Jul;185(1):74-79. doi: 10.1111/bjd.19713. Epub 2021 Feb 18.
6
Hidradenitis suppurativa: an update on epidemiology, phenotypes, diagnosis, pathogenesis, comorbidities and quality of life.化脓性汗腺炎:流行病学、表型、诊断、发病机制、合并症及生活质量的最新进展
J Eur Acad Dermatol Venereol. 2021 Jan;35(1):50-61. doi: 10.1111/jdv.16677. Epub 2020 Jul 16.
7
Burden, predictors and temporal relationships of comorbidities in patients with hidradenitis suppurativa: a hospital-based cohort study.患有化脓性汗腺炎患者的合并症负担、预测因素和时间关系:一项基于医院的队列研究。
J Eur Acad Dermatol Venereol. 2020 Mar;34(3):565-573. doi: 10.1111/jdv.15904. Epub 2019 Sep 16.
8
All-cause mortality among patients with hidradenitis suppurativa: A population-based cohort study in the United States.化脓性汗腺炎患者的全因死亡率:美国基于人群的队列研究。
J Am Acad Dermatol. 2019 Oct;81(4):937-942. doi: 10.1016/j.jaad.2019.06.016. Epub 2019 Jun 13.
9
Increased Suicide Risk in Patients with Hidradenitis Suppurativa.患有化脓性汗腺炎的患者自杀风险增加。
J Invest Dermatol. 2018 Jan;138(1):52-57. doi: 10.1016/j.jid.2017.09.008. Epub 2017 Sep 20.
10
STARD 2015 guidelines for reporting diagnostic accuracy studies: explanation and elaboration.《STARD 2015诊断准确性研究报告指南:解释与详述》
BMJ Open. 2016 Nov 14;6(11):e012799. doi: 10.1136/bmjopen-2016-012799.